Y. Jemiai

Semiparametric estimation of treatment effects given base‐line covariates on an outcome measured after a post‐randomization event occurs

A. Rotnitzky, Y. Jemiai, B. Shepherd, 2007, Journal of the Royal Statistical Society. Series B, Statistical methodology.

The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design

J. Wason, M. Proschan, M. Sydes, 2020, Trials.

The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease

S. Solomon, W. Manning, D. Lloyd‐Jones, 2011, Clinical trials.

A Consultant's Perspective on the Regulatory Hurdles to Adaptive Trials

C. Mehta, Y. Jemiai, 2006, Biometrical journal. Biometrische Zeitschrift.

Economic Evaluation of Cost and Time Required for a Platform Trial vs Conventional Trials

Jay J H Park, C. Mehta, J. Wathen, 2022, JAMA network open.

The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design

Douglas G. Altman, Philip Pallmann, Michael A. Proschan, 2019, BMJ.

Addressing Challenges and Opportunities of “Less Well-Understood” Adaptive Designs

Qi Jiang, Eva Miller, Paul Gallo, 2017, Therapeutic innovation & regulatory science.

DIA’s Adaptive Design Scientific Working Group (ADSWG): Best Practices Case Studies for “Less Well-understood” Adaptive Designs

Qi Jiang, Eva Miller, Paul Gallo, 2017, Therapeutic innovation & regulatory science.

The Case for a Bayesian Approach to Benefit-Risk Assessment: Overview and Future Directions

Weili He, Yannis Jemiai, Yueqin Zhao, 2017, Therapeutic innovation & regulatory science.

Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post‐Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials

Andrea Rotnitzky, Bryan E Shepherd, Peter B Gilbert, 2006, Biometrics.